19436-42-1

Basic information

• Product Name: 1-(4-Chlorobenzoyl)-2-(1-methylethyl)hydrazine
• Synonyms: 1-(4-Chlorobenzoyl)-2-(1-methylethyl)hydrazine
• CAS NO: 19436-42-1
• Molecular Formula: C₁₀H₁₃ClN₂O
• Molecular Weight: 0
• Mol File: 19436-42-1.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-(4-Chlorobenzoyl)-2-(1-methylethyl)hydrazine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-Chlorobenzoyl)-2-(1-methylethyl)hydrazine(19436-42-1)
• EPA Substance Registry System: 1-(4-Chlorobenzoyl)-2-(1-methylethyl)hydrazine(19436-42-1)

Safety Data

• Hazardous Substances Data: 19436-42-1(Hazardous Substances Data)

Usage

General Description

1-(4-Chlorobenzoyl)-2-(1-methylethyl)hydrazine is a chemical compound with the molecular formula C11H14ClN3O. It is a hydrazine derivative and has a chlorine-substituted benzoyl group as well as an isopropyl group. 1-(4-Chlorobenzoyl)-2-(1-methylethyl)hydrazine has been studied for its potential use in the treatment of various diseases, including cancer and neurodegenerative disorders. It is also used in research as a building block for the synthesis of other organic compounds. The specific properties and uses of 1-(4-Chlorobenzoyl)-2-(1-methylethyl)hydrazine depend on the context in which it is being employed, and it should be handled with appropriate safety precautions due to its potential hazards.

Upstream product

• 536-40-3 4-chlorobenzoic acid hydrazide 
• 86512-60-9 acetone-N-(4-chlorobenzoyl)hydrazone 

Downstream Products

• 1407499-52-8 (E)-tert-butyl 3-(3-(2-(4-chlorobenzoyl)-1-isopropylhydrazinyl)-3-oxoprop-1-enyl)-1H-indole-1-carboxylate 

Relevant articles and documents

Discovery of a novel series of indolyl hydrazide derivatives as diacylglycerol acyltransferase-1 inhibitors

A novel series of hydrazide derivatives were synthesized as potential diacylglycerol acyltransferase (DGAT) inhibitors. Among them, compounds 8u and 8v exhibited selective and potent DGAT-1 inhibitory activities. In addition, compound 8u dose-dependently inhibited triglyceride synthesis in HepG2 cell lines. Furthermore, treatment with compound 8u for an oral lipid tolerance test showed a significant decrease in plasma triglyceride levels compared with vehicle-treated control animals, indicating delayed absorption of triglyceride after an acute lipid challenge.